Projects and Grants per year
Personal profile
Research Interests
Phase I investigations, lung cancer, head and neck cancer, radiation-chemotherapy interactions, population studies in Appalachia.
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
1998
Doctor of Medicine, University Of Kentucky
1992
Bachelor of Arts, Brown University
1985
Residency, University Of Virginia
1985
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Susanne M Arnold is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Baculovirus-Based Minimally Invasive Therapy for Head and Neck Squamous Cell Carcinoma
Tong, S. (PI), Arnold, S. M. (CoI), Messaoudi Powers, I. (CoI) & Wang, C. (CoI)
National Institute of Dental and Craniofacial Research
8/6/26 → 7/31/31
Project: Research project
-
26-MULTI-72-REV-PMC (RMC-APEX-103): A Phase 1/2 Open-Label, Multicenter Study of RAS(ON) inhibitors in Combination with Ivonescimab with or without Other Anti-Cancer Agents in Patients with Solid Tumors
Villano, PhD, J. (PI), Anthony, L. (CoI), Arnold, S. M. (CoI), Baldwin Branch, L. (CoI), Fredericks, T. (CoI), Hao, Z. (CoI), Miller, R. (CoI), Myint, Z. (CoI), Pichardo Pernalete, R. (CoI), Selene, I. (CoI) & Ueland, F. (CoI)
Revolution Medicines Incorporated
7/31/26 → 7/31/28
Project: Research project
-
CCSG Pilot: COE: Understanding How to Implement Methionine Restriction to Improve Lung Cancer Treatments
Brainson, C. (PI), Arnold, S. M. (CoI), Gustafson, A. (CoI), Hao, Z. (CoI), Liu, J. (CoI) & Weiss, H. (CoI)
7/1/26 → 6/30/27
Project: Research project
-
25-HN-45-JJ (61186372HNC3001): A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants with Treatment-Na?ve Recurre
Arnold, S. M. (PI) & Zinner, R. (Former PI)
Janssen Research and Development LLC
2/2/26 → 2/2/28
Project: Research project
-
25-HN-43-PDS (PDS0101-HNC-301): A Phase 3 Open-Label, Randomized Study of PDS0101 Plus Pembrolizumab vs Pembrolizumab Alone in First Line Treatment of Immune Checkpoint Inhibitor (ICI) Naive Subjects with Unresectable Recurrent and/or Metastatic (R/M) Hum
Arnold, S. M. (PI)
8/21/25 → 8/21/27
Project: Research project
-
A case report of acute carcinoid heart failure during lutetium-177 dotatate–triapine treatment for well-differentiated neuroendocrine tumors
Chauhan, A., Kohn, E. C., Ivy, S. P., Kolesar, J. M., Modak, R., Arnold, S., Anthony, L., Carson, W. E., Shelman, N. R. & Kunos, C. A., 2026, In: Frontiers in Oncology. 16, 1801126.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
Bhatia, A., Chen, Z., Zhang, Y., Bruce, J. Y., Arnold, S., Kaur, V., Riess, J. W., Fenton, M., Burtness, B., Saba, N. F., Tara, H., Steuer, C. E., Shin, D. M., Wasp, G., Davis, T. H., Patel, M., Schmitz, J. C., Bhateja, P., Diavolitsis, V. & Zandberg, D. P. & 7 others, , Mar 15 2026, In: Cancer. 132, 6, e70346.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for clinicians
Hao, Z., Villano, J., Arnold, S. M. & Anthony, L., Jan 1 2026, In: Therapeutic Advances in Medical Oncology. 18Research output: Contribution to journal › Review article › peer-review
Open Access -
Genes associated with genetic and rare lung diseases and the risk of lung cancer
INTEGRAL-ILCCO Consortium, Apr 1 2026, In: BMC Cancer. 26, 1, 10 p., 461.Research output: Contribution to journal › Article › peer-review
Open Access -
Germline HLA heterozygosity is associated with decreased lung cancer risk
Tan, T., Shaw, V. R., Byun, J., Lee, H. S., Han, Y., Li, Y., Hung, R. J., Christiani, D. C., Wang, X. A., Johansson, M., Xiao, X., Zaridze, D., Bojesen, S. E., Shete, S., Albanes, D., Aldrich, M. C., Tardon, A., Fernandez-Tardon, G., Le Marchand, L. & Rennert, G. & 21 others, , Apr 9 2026, In: Human Genetics and Genomics Advances. 7, 2, 100567.Research output: Contribution to journal › Article › peer-review
Open Access